Zahid MF, Kainthla R. Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a RCSD1::ABL2 fusion gene. Leuk Lymphoma 2023 Oct 9:1-5. doi: 10.1080/10428194.2023.2264428.
PMID: 37812134